AGP Executive Report
Last update: 2 hours agoBiotech Breakthrough: Cambridge-based Scholar Rock says the FDA approved ISEMBYLD (apitegromab-mstn), a muscle-targeted treatment for spinal muscular atrophy in adults and children 2+ who are already on SMN2 therapies. Food Safety: Whole Foods Market issued an allergy alert and recall for Cabricharme cheese after undeclared egg lysozyme was found on labels, with distribution including Massachusetts. Healthcare Policy Fight: Mass. AG Kwame Raoul urged a federal appeals court to uphold a ruling blocking a Trump-era Affordable Care Act rule that would make it harder to keep coverage, arguing it could raise costs and leave more people uninsured. Local Planning Watch: The Martha’s Vineyard Commission is nearing a decision on the Katama Meadows subdivision, with proposed conditions including limits on swimming pools, solar requirements for new construction, and added permanent open space. Legal/Finance: Massachusetts justices signaled openness to considering financial hardship in pension-loss cases tied to overtime fraud, while a separate Mass. life sciences investor lawsuit alleges it was sidelined after lining up a $300M investment. Banking: BankFive promoted two leaders in Fall River and across its footprint, expanding roles tied to consumer lending and financial controls.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
